• Aucun résultat trouvé

For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com

N/A
N/A
Protected

Academic year: 2022

Partager "For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com"

Copied!
1
0
0

Texte intégral

(1)AbbVie Declares Quarterly Dividend NORTH CHICAGO, Ill., June 19, 2014 -- The board of directors of AbbVie Inc. (NYSE: ABBV) declared a quarterly cash dividend of $0.42 per share. The cash dividend is payable Aug. 15, 2014 to stockholders of record at the close of business on July 15, 2014. AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years. About AbbVie AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. In 2013, AbbVie employs approximately 21,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page. SOURCE AbbVie. WorldReginfo - 82e2199b-3ef4-4a74-a497-9cec5b4cfef3. CONTACT: Media: Adelle Infante, (847) 938-8745, or Investors: Liz Shea, (847) 935-2211.

(2)

Références

Documents relatifs

This paper examines the failure of development policy to date in Africa, analysing not only its effects but also its causes. In response to the question, "How to unleash the

In addition, after in-depth examination of the financial statements, the Supervisory Board approved the annual financial statements and consolidated financial statements as well

In addition, after obtaining the auditor‘s declaration of independence and after conclusion of a disclosure agreement, the Audit Committee prepared the Supervisory Board’s proposal

To research consisted in a documental study. On May 4 came a result of 408 research articles. We proceeded to make a document listing the items and placing their

The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most

Inverse Reinforcement Learning method enables a robot to learn a policy using discrete and finite MDP (Markov Decision Process) in which the states are derived from the robot’s

/ La version de cette publication peut être l’une des suivantes : la version prépublication de l’auteur, la version acceptée du manuscrit ou la version de l’éditeur. For

How has the focus of the industry shifted during these years, from the technical problems a tool should solve to an increased focus on “softer” issues such as usability, docu-